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The isthmic organizer, which is located at the midbrain–hindbrain boundary, is important for midbrain development. The mechanism by which
the development of the organizer is initiated and maintained is not well understood. Inactivation of the gene encoding the orphan nuclear receptor,
GCNF, diminishes the expression of secreted signaling molecules, Fgf8 and Wnt1, the paired box genes Pax2/5, En1/2, and homeodomain
transcription factor Gbx2; all of which are essential for isthmic organizer function. In addition, full neuronal differentiation is not observed in the
midbrain region of GCNF−/− embryos. Increased cell death may contribute to the loss of midbrain structure in GCNF−/− embryos. These results
indicate that GCNF is required for establishment of the isthmic organizer, thereby regulating the midbrain development.
© 2005 Elsevier Inc. All rights reserved.Keywords: Nuclear receptor; GCNF; Isthmic organizer; Midbrain–hindbrain boundaryIntroduction
Midbrain development has been extensively investigated,
and many transcription factors and secreted signaling
molecules have been shown to be involved in regulating its
development and function. Expression of the homeodomain
transcription factors, Otx2 and Gbx2, regulate anterior–
posterior patterning during brain development. Otx2 is
expressed in the presumptive forebrain and midbrain, while
Gbx2 is expressed in the presumptive hindbrain and spinal
cord. Studies reveal that the boundary region between the
Otx2 and Gbx2 expression domains, which is located at the
midbrain–hindbrain boundary (MHB), constitutes the orga-
nizing center, called the isthmic organizer (Joyner et al., 2000;
Wurst and Bally-Cuif, 2001).
Antagonistic regulation between Otx2 and Gbx2 regulates
the precise position of the isthmic organizer (Broccoli et al.,
1999; Millet et al., 1999), while other homeobox genes such
as Pax2/5 and En1/2 are required for isthmic organizer⁎ Corresponding author. Fax: +1 713 790 1275.
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doi:10.1016/j.ydbio.2005.12.017activity during early somitogenesis (Liu and Joyner, 2001b;
Urbanek et al., 1997). The isthmic organizer expresses
secreted signaling molecules such as Fgf8 and Wnt1 and
thereby induces the development of the midbrain and
anterior hindbrain (Crossley and Martin, 1995; Liu et al.,
1999; Martinez et al., 1999; Meyers et al., 1998), Fgf8
expression in the isthmic organizer terminates around
embryonic day (E) 13.5, while Wnt1 expression terminates
at E15.5 (Xu et al., 2000). Although the genes that maintain
the activities of isthmic organizer, such as homeobox genes,
have been characterized extensively, there is no report of
involvement of members of the nuclear receptor superfamily,
except Germ Cell Nuclear Factor, GCNF (Song et al.,
1999).
GCNF belongs to the nuclear receptor superfamily which
consists of several ligand-dependent transcription factors that
bind to steroids or non-steroids, such as retinoic acid (Aranda
and Pascual, 2001; Lee and Lee Kraus, 2001). Some members
of this superfamily are orphan receptors that are involved in
regulating embryonic development. GCNF has been shown to
be essential for normal embryonic development (Chung et al.,
2001; David et al., 1998; Lan et al., 2002). However, GCNF
was initially described to have tissue-specific expression in
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1995) and human (Agoulnik et al., 1998; Kapelle et al., 1997;
Lei et al., 1997), however, it is also expressed during
gastrulation (Chung et al., 2001; David et al., 1998; Heinzer
et al., 1998; Lei et al., 1997; Susens et al., 1997). In the
developing brain, GCNF is expressed in postmitotic neurons
of the marginal zone of the neuroepithelium at E15 (Agoulnik
et al., 1998; Bauer et al., 1997; Susens et al., 1997). Targeted
deletion of the GCNF gene results in embryonic lethality by
E10.5 with loss of proper repression of the Oct4 gene in
somatic cells (Chung et al., 2001; Fuhrmann et al., 2001; Lan
et al., 2002). In addition, the GCNF−/− embryos suffer from
generalized defects, such as failure of neural tube closure and
axial rotation. It has been shown that GCNF is a repressor of
gene transcription in cellular contexts through the binding to
GCNF DNA response element (DR0), which is a direct repeat
of the sequence AGGTCA separated by a zero-nucleotide
spacer (Cooney et al., 1998; Hummelke et al., 1998; Yan and
Jetten, 2000). For example, repression of Oct4 is mediated by
GCNF binding to a DR0 element in the proximal promoter
(Fuhrmann et al., 2001).
Recent in vitro studies in a mouse embryonic carcinoma cell
line demonstrate that GCNF is important for differentiation and
maturation of neuronal precursor cells (Sattler et al., 2004).
GCNF knockdown impairs the differentiation of neuronal
precursor cells and delays their maturation, suggesting that
GCNF may regulate neuronal differentiation in embryos. In
Xenopus, GCNF has also been reported to be required for
different patterns of cell intercalation during neurulation
(Barreto et al., 2003b). GCNF knockdown affects the medial
migration and radial intercalation. These defects may impair the
morphogenetic movements that close the neural tube. In
addition, GCNF can synergize with ectopic chordin to induce
the En2 expression in Xenopus (Song et al., 1999), which
together with results from gain- and loss-of-function experi-
ments, suggests that GCNF may play a role in the midbrain–
hindbrain formation (Song et al., 1999).
Here, we report that, in GCNF−/− mouse embryos,
expression of genes important for isthmic organizer function,
including Fgf8, Gbx2, Wnt1, En1/2, and Pax2/5, are signifi-
cantly down-regulated. In GCNF−/− embryos, cells in the
isthmic organizer do not differentiate fully into neurons.
Significant cell death may be the cause of loss of the midbrain
structures in GCNF−/− embryos. These results demonstrate that
GCNF is required to establish the organizer activity at the
isthmus, thereby regulating midbrain development.Materials and methods
Generation of GCNF knockout mice and genotypic analysis of
embryos
Mice deficient in GCNF were generated by gene targeting in embryonic
stem cells (ES cells) as previously described (Chung et al., 2001). Timed
matings of mice heterozygous for the GCNF mutation were initiated to obtain
litters at different developmental stages. All studies were performed on a 129Sv/
C57BL6 genetic background. Yolk sac DNA from each embryo was extracted
and genotyped by PCR as previously described (Chung et al., 2001).Whole-mount in situ hybridization (WMISH) and TUNEL assays
Embryos were obtained from heterozygote GCNF+/− crosses on embryonic
days 8.0–9.5. Embryos were fixed in MEMFA (0.2 M MOPS, pH7.4, 2 mM
EGTA, 1 mM MgSO4, 3.7% formaldehyde) at 4°C overnight. To examine the
expression of marker genes, whole-mount in situ hybridization (WMISH) was
used as previously described (Chung et al., 2001). cRNA probes for BF1
(Shimamura and Rubenstein, 1997), En1 (Danielian and McMahon, 1996), En2
(Conlon and Rossant, 1992), FGF8 (Crossley and Martin, 1995), Gbx2 (Millet
et al., 1999), Otx2 (Broccoli et al., 1999), Sprouty1 (Minowada et al., 1999),
Pax2 (Dressler et al., 1990), Pax5 (Schwarz et al., 1997),Wnt1 (McMahon et al.,
1992) were DIG labeled and used for the WMISH analyses.
Whole-mount TUNEL assay was performed as previously described (Qiu et
al., 1997). Briefly, embryos were first fixed in MEMFA, washed in 50%
methanol, and stored in 90%methanol at −20°C. After serial rehydration to PBT
(PBS with 0.1% Tween-20), the embryos were digested in 10 μg/ml proteinase
K in PBT. After rinsing in PBT, the embryos were postfixed in freshly prepared
4% paraformaldehyde in PBT. After 20 min in blocking solution (0.1% sodium
borohydride in PBT) at room temperature, the embryos were rinsed with TdT
buffer (30 mM Tris, pH 7.2, 140 mM Cacodylate, 1 mM CoCl2). Subsequently,
the embryos were incubated in a reaction mix (20 μm DIG-UTP, 20 μM dTTP,
and 0.3 U/ml Terminal transferase in TdT buffer) at 37°C for 2 h. Embryos were
washed extensively in PBT solution and incubated in blocking solution (2%
Blocking reagent (Roche) in PBT.3 [PBS with 0.3% Triton X-100]). Then
embryos were incubated with alkaline phosphatase-conjugated anti-digoxigenin
antibody at 4°C overnight. After washing in PBT.5 (PBS with 0.5% Triton X-
100), the WMISH signals were detected by incubating the embryos in BM
purple (Roche) solution in the dark. The color reaction was stopped by adding
1mM EDTA in PBT.3 solution.
Whole-mount immunohistochemistry
Whole-mount immunohistochemistry with a monoclonal antibody (2H3)
recognizing a 165-kDa neurofilament protein was performed essentially as
previously described (Qiu et al., 1997). Briefly, embryos were collected in PBS,
fixed in methanol:DMSO (4:1) overnight at 4°C. Embryos were then bleached in
methanol:DMSO:30% H2O2 (4:1:1) overnight at room temperature, rehydrated
for 30 min each through 70%, 50%, and 25% methanol, and finally PBS.
Embryos were incubated twice in PBSMT (2% instant skim milk powder, 0.1%
Triton X-100 in PBS) for 1 h at room temperature, then with primary
monoclonal antibody against alpha-neurofilament (2H3, Developmental Studies
Hybridoma Bank, IL) diluted (1:500) in PBSMT at 4°C overnight. Embryos
were washed in PBSMT twice at 4°C and 3 times at room temperature for 1
h each, followed by an overnight incubation at 4°C with peroxidase-conjugated
goat anti-mouse IgG (Santa Cruz, CA) diluted (1:1000) in PBSMT. The washes
were similar to washes after the primary antibody one with an additional 20-min
wash in PBT (0.2% BSA, 0.1% Triton X-100 in PBS) at room temperature. For
the color reaction, embryos were incubated with 0.3 mg/ml of diaminobenzidine
tetrahydrochloride (Sigma) in PBT for 30–60 min at room temperature and
visualized by addition of H2O2 to 0.0003% and incubation at room temperature.
Embryos were then rinsed in PBT to stop the reaction, dehydrated through a
methanol series; 25%, 50%, 70%, 100% for 30 min each, and cleared in benzyl
alcohol:benzyl benzoate (1:2).Results
GCNF is expressed in the neuroectoderm during early
somitogenesis
GCNF is expressed in wild-type (WT) mouse embryos as
early as E6.5 (Fuhrmann et al., 2001). At the onset of
somitogenesis at E8.0, GCNF expression appeared in the
proliferating neuroepithelium, with a gradient from the
posterior to anterior ends (Fig. 1A). Its expression has also
been reported to be present in the underlying mesoderm
Fig. 2. Expression of Otx2 and Gbx2 in GCNF+/+ and GCNF−/− embryos during
early mouse embryonic development. (A, B) WMISH analysis of Otx2
expression in embryos with one to two somites at E8.0. (C, D) WMISH
analysis of Otx2 expression at E8.5 in embryos with six somites. Similar Otx2
expression patterns were observed in the anterior region of GCNF+/+ and
GCNF−/− embryos at E8.0 and E8.5. (E, F) WMISH analysis of Otx2 expression
at E9.5 in WT embryos with 25 somites and in GCNF−/− embryos with 13
somites. Otx2 expression domain of GCNF−/− embryos extended to the first
branchial arch (black arrows). (G, H) WMISH analysis of Gbx2 expression in
embryos with one to two somites at E8.0. (I, J) WMISH analysis of Gbx2
expression at E8.5 in embryos with eight somites. Gbx2 expression at the MHB
was not detected in GCNF−/− embryos at E8.5. (K, L) WMISH analysis of Gbx2
expression at E9.5 in WT embryos with 25 somites and in GCNF−/− embryos
with 13 somites. No Gbx2 expression was observed in the midbrain region of
GCNF−/− embryos. White arrows indicate the position of MHB. Insets are dorsal
views of the midbrain region of the embryos.
Fig. 1. Expression of GCNF in wild-type mouse embryos. Whole-mount in situ
hybridization analysis of on WT embryos with GCNF DIG-labeled cRNA
probe. (A) GCNF expression in a mouse embryo with three somites at E8.0, (B)
GCNF expression in a mouse embryo with six somites at E8.5, (C) GCNF
expression in a mouse embryo with 13 somites at E8.75, and (D) GCNF
expression in a mouse embryo with 25 somites at E9.5.
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anterior neuroepithelium at E8.5 in embryos with six somites
(Fig. 1B). Subsequently, GCNF expression decreased in the
anterior after E8.75 when the somite number was greater than
12 (Fig. 1C). By E9.5, in embryos with 25 somites, GCNF
expression was markedly reduced in the forebrain and
midbrain regions as determined by whole-mount in situ
hybridization assay (Fig. 1D).
Loss of GCNF function down-regulates the expression of Gbx2,
Fgf8, BF1, and Spry1 in the forebrain region, but not Otx2
The earliest anterior neuroectoderm marker gene that is
expressed is Otx2, a homeodomain transcription factor, which
is expressed in the visceral endoderm and in the epiblast prior
to the onset of gastrulation (Broccoli et al., 1999). After
gastrulation, Otx2 expression becomes progressively restricted
to the anterior region of the embryo (Fig. 2A). During
somitogenesis at E8.5 and E9.5 (with six and 25 somites,
respectively), the Otx2 expression domain defines the
prospective forebrain and midbrain territory (Figs. 2C, E). In
GCNF−/− embryos, Otx2 was also expressed in the anterior
region of the embryos during the onset of somitogenesis (Fig.
2B). At E8.5 in embryos with six somites, Otx2 is expressed
in the forebrain region of GCNF−/− embryos (Fig. 2D). At
E9.5 in embryos with 13 somites, Otx2 expression extended
caudally and reached the first branchial arch in GCNF−/−
embryos (Black arrow in Fig. 2F).
Fig. 3. Expression of Fgf8 in GCNF+/+ and GCNF−/− embryos during early
mouse embryonic development. (A, B) WMISH analysis of Fgf8 expression at
E8.5 in embryos with six somites. (C, D) WMISH analysis of Fgf8 expression at
E9.5 in WTembryos with 25 somites and in GCNF−/− embryos with 13 somites.
Fgf8 expression was significantly reduced in the midbrain (white arrows) and
ANR (black arrows) region of GCNF−/− embryos. White arrows indicate the
position of the MHB. Insets are dorsal views of the midbrain region of the
embryos.
Fig. 4. Expression of BF1, and Sprouty1 in GCNF+/+ and GCNF−/− embryos
during early mouse embryonic development. (A, B) WMISH analysis of BF1
expression at E8.5 in embryos with six somites. (C, D) WMISH analysis of BF1
expression at E9.5 in WT embryos with 25 somites and in GCNF−/− embryos
with 13 somites. Weak BF1 expression was detected in the anterior region of
GCNF−/− embryos at E8.5, and its expression is absent at E9.5 in GCNF−/−
embryos. (E, F) WMISH analysis of Sprouty1 expression at E8.5 inWTembryos
with eight somites and in GCNF−/− embryos with six somites. (G, H) WMISH
analysis of Sprouty1 expression at E9.5 in WT embryos with 25 somites and in
GCNF−/− embryos with 13 somites. Sprouty1 expression was not observed in the
midbrain region ofGCNF−/− embryos at E9.5. Black arrows indicate the anterior
neural ridge. White arrows indicate the position of the MHB.
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expressed throughout the posterior of WT embryo at E7.5
(Millet et al., 1999). After gastrulation, Gbx2 expression
becomes progressively restricted to the posterior region of the
head-fold (Fig. 2G). At E8.5, in embryos with eight somites,
Gbx2 is expressed in the prospective hindbrain (rhombomere 1)
(white arrow in Fig. 2I) and presomitic mesoderm (PSM) (Fig.
2I) (Garda et al., 2001). At E9.5, in embryos with 25 somites,
anterior Gbx2 expression is restricted to the MHB (white arrow
in Fig. 2K). In GCNF−/− embryos, similar posterior Gbx2
expression was observed once somitogenesis initiated (Fig.
2H). At E8.5, in GCNF−/− embryos with six somites, anterior
Gbx2 expression was not detected in the MHB (white arrow in
Fig. 2J). Gbx2 expression was not detected in the MHB, but it
was weakly expressed along the anterior neuroepithelium at
E9.5 in GCNF−/− embryos with 13 somites (Fig. 2L). The
boundary of the Otx2 and Gbx2 expression defines the position
of the MHB. Since Gbx2 expression was lost in the MHB, it
suggested that there might be a defect in the development of
isthmic organizer in GCNF−/− embryos.
At the three somite stage, a secreted member of the fibroblast
growth factor (Fgf) family, Fgf8, is expressed, initially, in a
broad domain confined to the rostral part of the Gbx2-positive
territory (Crossley and Martin, 1995). At E8.5 in embryos with
six somites, Fgf8 was expressed in the prospective midbrain
region and in the anterior neural ridge as expected (ANR) (Fig.
3A). Fgf8 is then expressed in the MHB and ANR at E9.5 in
embryos with 25 somites (Fig. 3C). In GCNF−/− embryos, Fgf8
expression was weakly expressed in the head-fold, and its
expression was significantly reduced in the ANR at both E8.5
and E9.5 (six and 13 somites, respectively) (Figs. 3B, D).
BF1, a gene encoding a transcription factor required for
regionalization and growth of the telencephalic and opticvesicles, is expressed in the ANR of mouse embryos at E8.5
(Shimamura and Rubenstein, 1997) (Figs. 4A, C). Recombinant
Fgf8 protein is capable of inducing BF1 expression, thus Fgf8
regulates the development of anterolateral neural plate deriva-
tives (Shimamura and Rubenstein, 1997). Since Fgf8 expres-
sion is down-regulated in the ANR of GCNF−/− embryos, we
examined the expression of BF1. In WT embryos, BF1
expression is maintained in the ANR from E8.5 to E9.5 in
embryos with six and 25 somites, respectively (Figs. 4A, C). In
GCNF−/− embryos, BF1 transcript was weakly expressed in the
ANR at E8.5 in embryos with six somites (Fig. 4B) and absent
at E9.5 in embryos with 13 somites (Fig. 4D).
Sprouty expression is also dependent on Fgf signaling and
Sprouty can antagonize Fgf function (Minowada et al., 1999).
Thus, Sprouty plays an essential role in feedback loop of Fgf
signaling (Sivak et al., 2005). Sprouty1 expression is induced by
Fgf8, and it is expressed in the MHB during early somitogenesis
Fig. 5. Expression of Pax2, En1, and Wnt1 in GCNF+/+ and GCNF−/− embryos
during early mouse embryonic development. (A, B) WMISH analysis of Pax2
expression at E8.5 in embryos with four somites. (C, D) WMISH analysis of
Pax2 expression at E8.75 in embryos with 13 somites. Weak Pax2 expression
was observed in the anterior region of GCNF−/− embryos at E8.0 and E8.5. (E,
F) WMISH analysis of Pax2 expression at E9.5 in WT embryos with 30 somites
and in GCNF−/− embryos with 13 somites. Pax2 expression was undetectable in
GCNF−/− embryos at E9.5. (G, H) WMISH analysis of En1 expression at E8.75
in WT embryos with 13 somites and in GCNF−/− embryos with 10 somites. En1
was weakly expressed in GCNF−/− embryos at E8.75. (I, J) WMISH analysis of
Wnt1 expression at E8.5 in embryos with eight somites. (K, L) WMISH analysis
of Wnt1 expression at E9.5 in WT embryos with 30 somites and in GCNF−/−
embryos with 13 somites. No Wnt1 expression was observed in the midbrain
region of GCNF−/− embryos at E9.5. White arrows indicate the position of
MHB. Insets are dorsal views of the midbrain region of the embryos.
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(Figs. 4E, G). In GCNF−/− embryos, Sprouty1 expression in the
MHBwas undetectable at E8.5 and E9.5 in embryos with six and
13 somites, respectively (Figs. 4F, H). Clearly, Fgf8 signaling in
the anterior of GCNF−/− embryos was severely impaired.
The isthmic organizer is not established properly in GCNF−/−
embryos
To examine whether the isthmic organizer was affected in
the GCNF−/− embryos, we investigated the expression of
genes that are important for isthmic organizer function. The
expression of the isthmus-specific paired box transcription
factor, Pax2, is initiated at the presomitic head-fold stage
around the Otx2/Gbx2 boundary, and it is the first gene
expressed in the MHB and the tip of forebrain during early
somitogenesis (Dressler et al., 1990). At E8.5 in embryos with
four somites and E8.75 in embryos with 13 somites, Pax2 was
expressed in the prospective MHB (Figs. 5A, C). Pax2
expression was maintained at the MHB at E9.5 in embryos
with 30 somites (Fig. 5E). In GCNF−/− embryos, Pax2 was
weakly expressed at the onset of somitogenesis at E8.5 when
the somite number was four (Fig. 5B), however, its expression
was undetectable in the MHB in embryos with somite
numbers greater than five (Figs. 5D, F). These results suggest
that the development of isthmic organizer was already affected
in the GCNF−/− embryos by E8.5.
Once somitogenesis initiates, expression of the home-
odomain transcription factor engrailed 1 (En1) and the
secreted glycoprotein signaling molecule Wnt1 are simulta-
neously initiated within the Pax2 expression domain (Danie-
lian and McMahon, 1996; McMahon et al., 1992). In mouse
embryos with somite numbers between 8 to 13, En1 and Wnt1
were co-expressed across the Otx2/Gbx2 border in the
midbrain and hindbrain (Figs. 5G, I). Later at E9.5 in
embryos with 28 somites, Wnt1 expression is largely confined
to the posterior Otx2-positive domain and is restricted to a
narrow ring encircling the neural tube rostral to the isthmic
constriction and the dorsal and ventral midline of the
mesencephalon (Fig. 5K). In GCNF−/− embryos that had
greater than five somites, En1 and Wnt1 were weakly
expressed (Figs. 5H, J). At E9.5 in GCNF−/− embryos with
13 somites, Wnt1 was expressed along the ridge of
neuroectoderm, but its characteristic ring-like expression
around the MHB was not observed (Fig. 5L).
At the three somite stage, Fgf8 is expressed in a region
confined to the rostral part of the Gbx2-positive territory
(Crossley and Martin, 1995). At E8.5 in embryos with six
somites, Fgf8 expression was found in the prospective MHB
(Fig. 3A). Fgf8 was then expressed in the MHB at E9.5 in
embryos with 25 somites (Fig. 3C). In GCNF−/− embryos at
both E8.5 with six somites and at E9.5 with 25 somites,
Fgf8 expression was barely detectable in the midbrain region
(Figs. 3B, D).
At the five somite stage, transcription of the another paired
box gene Pax5 and the homeobox gene engrailed 2 (En2) is
initiated in a broad region overlapping the Otx2/Gbx2 boundary
Fig. 6. Expression of Pax5 and En2 in GCNF+/+ and GCNF−/− embryos during
early mouse embryonic development. (A, B) WMISH analysis of Pax5
expression at E8.5 in WTembryos with seven somites and in GCNF−/− embryos
with six somites. (C, D) WMISH analysis of Pax5 expression at E9.5 in WT
embryos with 30 somites and in GCNF−/− embryos with 13 somites. Pax5
expression was significantly reduced in GCNF−/− embryos. (E, F) WMISH
analysis of En2 expression at E8.5 in WT embryos with seven somites and in
GCNF−/− embryos with six somites. (G, H) WMISH analysis of En2 expression
at E9.5 in WT embryos with 30 somites and in GCNF−/− embryos with 13
somites. No En2 expression was detected in the anterior region of GCNF−/−
embryos at E8.5 and E9.5. White arrows indicate the position of MHB. Insets
are dorsal views of the midbrain region of the embryos.
Fig. 7. Analysis of apoptosis and cranial nerve development in GCNF+/+ and
GCNF−/− embryos. (A–D) Whole-mount TUNEL assays in WT embryos with
30 somites and in GCNF−/− embryos with 13 somites at E9.5. (A, B) Lateral
views. (C, D) Dorsal views. Significant increase in cell death was observed in
GCNF−/− embryos compared to WTembryos. (E, F) Whole-mount staining with
antibody against alpha-neurofilament in WT embryos with 30 somites and in
GCNF−/− embryos with 13 somites at E9.5. Note that the cranial nerves
connected to the midbrain (III and IV) were underdeveloped in GCNF−/−
embryos at E9.5.
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were expressed in the prospective MHB at E8.5 in embryos with
seven somites (Figs. 6A, E). Subsequently, the expression
domains of both these marker genes are refined to highly
ordered pattern in the MHB at E9.5 in embryos with 30 somites
(Figs. 6C, G). In GCNF−/− embryos, Pax5 mRNA was not
detected in the prospective MBH region during early somito-
genesis when the somite number was six (Fig. 6B). Weak Pax5
expression was observed at E.9.5 in GCNF−/− embryos with 13
somites in a ridge of neuroectoderm, while the medial Pax5
expression was lost (Fig. 6D). In GCNF−/− embryos at the six
somite stage, En2 was barely detectable in the midbrain region
(Fig. 6F). Subsequently, En2 transcript was undetectable in the
GCNF−/− embryos with 13 somites at E9.5 (Fig. 6H). Loss of the
expression of midbrain marker genes in the GCNF−/− embryos
suggests that GCNF may play an important role of midbrain
formation.Significant cell death and loss of neuronal differentiation in the
midbrain region of GCNF−/− embryos
Loss of Fgf8 expression causes significant cell death in the
midbrain, leading to complete loss of this structure (Chi et al.,
2003). The loss of Wnt1 and Pax2/5 expression in the isthmic
organizer of GCNF−/− embryos could be due to apoptosis of the
organizer cells. To examine this possibility, a whole-mount
TUNEL assay was performed on WT and GCNF−/− embryos.
This assay demonstrated that there was significant difference in
cell death between the WTandGCNF−/− embryos at E9.5 (Figs.
7A–D), thus suggesting the possibility that cell death may
contribute to the loss of the midbrain development in the GCNF
mutants.
To determine whether the many molecular alterations
detected in GCNF−/− embryos affect cranial nerve patterning,
E9.5 embryos were immunostained with an anti-neurofilament
antibody. Normally, cranial nerves III and IV are derived from
the midbrain and the isthmic organizer at E9.5 in WT embryos
with 30 somites (Fig. 7E). Whole-mount staining with antibody
to neurofilament revealed that the cranial nerves normally
connected with the midbrain (such as III and IV) did not
develop well at E9.5 inGCNF−/− embryos with 13 somites (Fig.
7F). These results are consistent with the severely impaired
midbrain development in GCNF−/− embryos. We conclude that
Fig. 8. Schematic representation of the expression of the marker genes of the forebrain and isthmic organizer observed in GCNF−/− embryos relative to wild-type
embryos. (A, B) In WT embryos, Otx2 is expressed in the rostral neural tube and Gbx2 is expressed in the posterior neural tube overlapping at the prospective MHB
(pMHB) (expression is only shown unilaterally for clarity). Although similar expression patterns are observed in GCNF−/− embryos, Gbx2 expression is significantly
down-regulated. Although the defects of neuronal differentiation in the midbrain are depicted at E9.5, the expressions of the MHB marker genes, which was analyzed
at E8.5 (prior to the appearance of these defects), are significantly reduced in GCNF−/− embryos. The gene expression patterns are shown as bars and displayed
positionally (anterior–posterior) relevant to the cartoon depicting a dorsal view of the developing brain with superimposed Otx2 and Gbx2 expression domain. (C, D)
There are two possible mechanisms of how GCNF affects the expression of the midbrain marker genes. GCNF represses the expression of a down stream repressor,
which antagonizes the expression of a transcriptional activator that normally regulates the expression of midbrain marker genes (Model I in C). Loss of GCNF function
leads to up-regulation of this repressor which in turn leads to the repression of the activator diminishing the expression of midbrain marker genes (Model I in D).
Alternatively, GCNF, an orphan receptor, may bind a ligand, which transforms it into a transactivator that directly regulates the expression of midbrain marker genes
(Model II in C). Loss of GCNF expression leads to diminished expression of midbrain marker genes (Model II in D).
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patterning of their cranial nerve derivatives.
Discussion
The expression pattern of GCNF during early mouse
embryonic development suggests a role in neuronal develop-ment. GCNF is expressed as early as the egg cylinder stage
(Chung et al., 2001). After gastrulation, GCNF expression is
detected in the head-fold and throughout the primitive streak. A
posterior–anterior gradient of GCNF expression develops by
the neural stage (Chung et al., 2001). By the late neural stage,
GCNF expression is markedly reduced (Susens et al., 1997). At
E15, GCNF is expressed in the postmitotic neurons of the
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Inactivation of GCNF gene results in a failure of neural tube
closure. (Chung et al., 2001; Fuhrmann et al., 2001; Lan et al.,
2002). In addition, GCNF is required to regulate the
differentiation and maturation of neuronal precursor cells
(Sattler et al., 2004). In Xenopus, GCNF is important for cell
intercalation during neurulation (Barreto et al., 2003b). In
addition, GCNF can synergize with ectopic chordin to induce
the En2 expression in Xenopus (Song et al., 1999).
In this study, we investigated brain development inGCNF−/−
embryos and observed that expression of Otx2, Gbx2, En1/2,
and Pax2/5 was significantly altered in the midbrain–hindbrain
region. These results indicate that the isthmic organizer is not
established by E9.5 in the absence of GCNF. At E9.5, both
Wnt1 and Fgf8 expression disappears in the region where the
isthmic organizer should form in the GCNF−/− embryos, thus,
GCNF may play an important role in either establishing or
maintaining midbrain formation and signaling.
Loss of GCNF function affects normal forebrain development
The anterior neural ridge (ANR) is a specific structure at the
junction of anterior neural plate and the non-neural ectoderm
(Eagleson et al., 1995). Fgf8 is expressed along the apex of
ANR, and alteration of Fgf8 levels can affect the forebrain
development by affecting cell survival (Storm et al., 2003).
After neural tube closure, Fgf8 expression is localized in the
region of the rostral midline of the telencephalon. Inactivation
of Fgf8 expression in this region increases apoptosis and
reduces Spry1 expression (Storm et al., 2003). These results are
similar to what we observed in GCNF−/− embryos. In addition,
ANR expression of Fgf8 has been shown to be vital for the
induction and maintenance of BF1 (Shimamura and Ruben-
stein, 1997). Loss of BF1 expression induces hypoplasia of the
cerebral hemispheres. Thus, the ANR expression of Fgf8
regulates growth of the telencephalon. In a similar manner, the
isthmus also expresses Fgf8 and controls midbrain patterning,
the ANR has also been proposed to be another local organizer
for telencephalon development (Storm et al., 2003).
Forebrain development is controlled by factors, such as
Otx2. Otx2 expression is required during gastrulation in the
anterior visceral endoderm for induction of head tissue anterior
to r3 (Li and Joyner, 2001). If Otx2 expression is altered, the
forebrain and midbrain will not be specified normally (Liu and
Joyner, 2001a). Marker gene analysis showed that the domains
of expression of Wnt1, Fgf8, En1, and Pax2 are shifted to the
anterior of the neural tube from early somite stages, and their
expression patterns overlap. It appears that the forebrain and
midbrain are initially specified and then forebrain cells die, and
the midbrain may be transformed into more posterior tissue. In
contrast, Gbx2 null mutants lack anterior hindbrain tissue
derived from r1–3 (Li et al., 2002), whereas GCNF−/− embryos
do have anterior hindbrain rhombomeres (date not shown). At
early somite stages, the domain of Otx2 is expanded into the
presumptive metencephalon in Gbx2 mutants, before a
morphological defect is obvious (Millet et al., 1999). Fgf8
and Wnt1 expression overlap and are also shifted and expandedposteriorly, indicating that an early defect in Gbx2 mutants is a
transformation of r1–3 into a midbrain fate. Thus, loss of Gbx2
expression in the GCNF−/− embryos may also affect hindbrain
development.
Loss of GCNF function may affect normal midbrain
development
Since GCNF−/− embryos die at E10, it is unclear whether the
midbrain is completely deleted in these embryos. But compared
to the previous studies of midbrain development, it is clear that
the midbrain is underdeveloped in GCNF−/− embryos. Deletion
of portions of the midbrain is found in Wnt1 (McMahon and
Bradley, 1990), En1/2 (Joyner, 1996), and Pax2 (Bouchard et
al., 2000) null mutant mouse embryos. In zebrafish embryos,
loss of a Pax2 ortholog and ace, an Fgf8 hypomorph, also
causes deletion of the midbrain to the cerebellum (Brand et al.,
1996; Lun and Brand, 1998; Reifers et al., 1998). Studies in
Fgf8 hypomorphs also demonstrate that a substantial portion of
the midbrain, as well as the isthmus and cerebellum, are deleted
(Meyers et al., 1998). Recent studies employing a conditional
inactivation of Fgf8 expression in the mes/met region
demonstrated a complete deletion of the midbrain and
cerebellum in these mouse embryos (Chi et al., 2003). Since
the expression of these important midbrain marker genes, Fgf8,
Wnt1, Pax2/5, and En1/2, are significantly reduced or
eliminated in GCNF−/− embryos (summarized in Fig. 8),
midbrain development is significantly hindered. Thus, GCNF
plays a critical role in midbrain development, potentially at the
level of transcriptional regulation.
Although a detailed mechanism of how GCNF affects the
expression of the midbrain marker genes is still unclear, there
are two possibilities (Figs. 8C and D). In model I, GCNF, a
known transcriptional repressor, normally represses the expres-
sion of a down stream repressor, which antagonizes the
expression of a transcriptional activator that normally regulates
the expression of midbrain marker genes (Model I in Fig. 8C).
Loss of GCNF function leads to up-regulation of the repressor,
which in turn leads to the repression of the midbrain marker
genes, such as En1/2, Fgf8, Pax2/5, and Wnt1 (Model I in Fig.
8D). Alternatively, GCNF, an orphan receptor, may bind a
ligand, which transforms it into a transactivator that directly
regulates the expression of midbrain marker genes (Model II in
Fig. 8C). Loss of GCNF expression leads to diminished
expression of midbrain marker genes (Model II in Fig. 8D). We
cannot rule out that in addition to these direct roles in
transcriptional regulation, loss of GCNF function may alter
cell lineage properties in the brain. In the absence of GCNF, the
precursor cells of the midbrain may alter their cell fate rendering
them unable to properly express midbrain markers.
Retinoic acid (RA) plays an important role in hindbrain
development (Gavalas, 2002). RA can alter the expression of
the marker genes during development of the MHB (Avan-
taggiato et al., 1996). It has been proposed that GCNF may
be involved in RA signaling (Barreto et al., 2003a; Heinzer et
al., 1998). Addition of RA to P19 embryonic carcinoma cells
GCNF expression (Bauer et al., 1997; Fuhrmann et al., 2001).
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expression can alter Cyp26A1 expression, which in turn
affects RA signaling (Barreto et al., 2003a). However, when
we compared the phenotypic alteration of the gain- and loss-
of-function mutants of RA signaling (Raldh2 and Cyp26A1
mutants) with GCNF−/− embryos, their results differed from
those in the GCNF−/− embryos in important ways (Abu-Abed
et al., 2001; Niederreither et al., 1999, 2000; Sakai et al.,
2001). En2, Fgf8, and Gbx2 expression patterns are not
altered in Raldh2−/−embryos and nor is En2 expression
altered in Cyp26A1−/−embryos (Abu-Abed et al., 2001;
Niederreither et al., 2000). These two results suggest that
absence or alteration of RA does not affect midbrain
development or at least not to a degree observed in the
GCNF−/− embryos. In addition, we did not detect any
difference in endogenous RA signaling in the MHB using
RARE-lacZ transgenic reporter mice crossed with GCNF−/−
embryos (data not shown). Although loss of GCNF function
does affect RA signaling during posterior hindbrain develop-
ment (data no shown), the loss of expression of isthmic
marker genes is unlikely to be directly due to the alteration of
RA signaling in the MHB.
Comparison of phenotypes in GCNF−/− embryos with previous
studies of Fgf8 mutant embryos
Since Fgf8 expression in the MHB is significantly reduced in
GCNF−/− embryos, loss of GCNF function may show similar
phenotypes to Fgf8 hypomorphs or the Fgf8 MHB conditional
knockout (MHB KO) embryos. There are several similarities
between GCNF−/− embryos and Fgf8-deficient embryos. First,
Fgf8 is required to maintain Wnt1 and Gbx2 expression in the
rostral metencephalon (Garda et al., 2001; Liu et al., 1999;
Martinez et al., 1999). Therefore, in Fgf8 hypomorphs and Fgf8
MHB KO embryos, expression of Wnt1 and Gbx2 in the MHB
is undetectable (Chi et al., 2003; Meyers et al., 1998). Gbx2
expression in the MHB determines the posterior limit of Otx2
expression (Li and Joyner, 2001; Li et al., 2002). Similarly in
Fgf8 MHB KO embryos, Gbx2 expression in rhombomere 1 is
absent, and Otx2 expression extends caudally (Chi et al., 2003).
Interestingly, in E9.5 GCNF−/− embryos, Otx2 expression is
extended caudally while Gbx2 expression is down-regulated in
the anterior hindbrain. This defect is probably the result of
down-regulation of Fgf8 expression, since Fgf8 is required to
maintain Gbx2 expression (Liu et al., 1999; Martinez et al.,
1999); in turn Gbx2 is required to repressOtx2 expression in the
hindbrain (Wassarman et al., 1997; Millet et al., 1999).
Alternatively, it is also possible that deregulation of Otx2 and
Gbx2 expression leads to disruption of the isthmic organizer and
loss of Fgf8 expression in GCNF−/− mice. However, since this
deregulation occurs only after the disappearance of Fgf8
expression after E8.5, it is likely that the disappearance of
Fgf8 expression leads to the loss of Otx2 and Gbx2 expression.
On the other hand, expressions of Pax2, En1, and Spry2,
which are thought to be regulated by Fgf8 (Wurst and Bally-
Cuif, 2001), are not significantly reduced in Fgf8 MHB KO
embryos. In GCNF−/− embryos, expressions of Pax2, En1, andSpry1 are undetectable in the midbrain region. This difference
can be explained by the different levels of Fgf8 transcript in the
embryos at the onset of midbrain development. In the Fgf8
MHB KO embryos, the level of Fgf8 expression, before the
Fgf8 gene is inactivated at E8.5, may be sufficient to initiate and
maintain the expression of Pax2, En1, and Spry2 in contrast to
what is observed in the GCNF−/− embryos.
Differences between xGCNF and mGCNF
The results of this study highlight some interesting
similarities and differences between the function of GCNF in
amphibians and mammals. First, GCNF is important for both
amphibian and mammalian midbrain development. In Xenopus,
GCNF synergizes with ectopic chordin to induce En2
expression in animal cap assays (Song et al., 1999). In Keller
explants, which rely on endogenous factors for neural
induction, GCNF can induce En2 expression (Song et al.,
1999). Injection of a dominant negative form of GCNF is
capable of reducing En2 expression (Song et al., 1999). In our
study, loss of GCNF function significantly reduces expression
of important regulatory genes in midbrain development. Taken
together, results from these two animal models demonstrate that
GCNF plays an evolutionarily conserved role in regulating
midbrain development.
In contrast to the results in this study, the GCNF knockdown
experiments in Xenopus demonstrates different results with
respect to the regulation of gene expression in the forebrain and
midbrain regions. In Xenopus, both Otx2 and Gbx2 are
expressed, but their expression domains are shifted caudally,
suggesting a repositioning of the MHB (Barreto et al., 2003a).
Similarly, En2 and Pax2 are expressed in the midbrain region,
and their expression domains are also shifted caudally after
GCNF knockdown (Barreto et al., 2003a). These results suggest
an expansion of anterior structures of the forebrain and midbrain
with simultaneous loss of posterior structures, such as anterior
hindbrain. In mice, loss of function of GCNF reduces the
expression of En2, Gbx2, and eliminates expression of Pax2 in
the MHB. These differences may be due to differences in
expression of marker genes or important regulatory factors
during embryonic development in the two species (Chung et al.,
2001) or differences in experimental design.
Comparison of GCNF−/− mouse embryos with the zebrafish
spiel ohne grenzen (spg) mutant embryos
Recent studies of zebrafish mutant embryos reveal that the
pou2 gene, which is the zebrafish ortholog of mouse Oct4,
which is a GCNF target gene in mice, and human Pou5f1, plays
an important role in midbrain development (Belting et al., 2001;
Fuhrmann et al., 2001; Reim and Brand, 2002). Spg mutant
embryos, which have lesions in the pou2 gene, display a unique
phenotype in midbrain and hindbrain development (Belting et
al., 2001), and ubiquitous Oct4 expression in transgenic mice
suggests that the mammalian Oct4 gene may also play a role in
brain development (Ramos-Mejia et al., 2005). In mice, Oct4 is
transiently expressed in the neuroepithelium of the head-fold
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and Brand, 2002). At the onset of somitogenesis, Oct4
expression is down-regulated in somatic cells and is restricted
to primordial germ cells (Fuhrmann et al., 2001). We have
clearly demonstrated that GCNF is able to repress Oct4
expression and loss of GCNF expression leads to derepression
of Oct4 expression in the head-fold and posterior regions at
E8.5 and E9.5 and in GCNF−/− ES cells (Fuhrmann et al., 2001;
Gu et al., 2005). It raises the question as to whether derepression
of Oct4 expression contributes to the midbrain defects in
GCNF−/− embryos.
In zebrafish spg mutant embryos, the MHB is not
established, and the midbrain is reduced in size (Belting et al.,
2001; Reim and Brand, 2002). Despite normal expression of
Otx2, Gbx1, and Fgf8 during late gastrulation, the initial
expression of Gbx2, Pax2.1, and En2, and later expression of
Fgf8 and Wnt1 in the MHB, are reduced (Belting et al., 2001;
Reim and Brand, 2002). Pax2.1 expression in spg mutant
embryos can be restored by injection of Pou2 or even murine
Oct4mRNA, suggesting that Oct4 may function in activation of
Pax2 in normal midbrain development (Belting et al., 2001;
Reim and Brand, 2002). Since the injection of pou2 mRNA in
normal or high doses does not induce ectopic expression of
midbrain markers (Belting et al., 2001; Burgess et al., 2002;
Reim and Brand, 2002), pou2 is necessary but not sufficient to
induce midbrain markers, demonstrating a permissive role for
the pou2 gene in midbrain development.
In addition, the phenotypes of spgmutants are similar to ace/
Fgf8 mutants, suggesting that the functions of these genes are
closely related (Reim and Brand, 2002). Pou2 is shown to be a
factor that mediates the competence to respond to Fgf8.
Injection of Fgf8 mRNA or implantation of Fgf8 beads in spg
mutants does not cause any effect (Reim and Brand, 2002).
Similarly, injection of pou2 mRNA fails to restore ace's
phenotypes. Synergistic effects on midbrain markers in the spg/
ace double mutants suggest that pou2 and Fgf8 act together
(Reim and Brand, 2002).
It is quite interesting to compare the phenotypes of
GCNF−/− mouse embryos and spg zebrafish mutant embryos.
Both have a loss or reduced expression of midbrain markers
and structures. The major difference between these two
models is the expression of Oct4. In zebrafish spg mutants,
Oct4 expression is reduced, while in the GCNF−/− embryos,
Oct4 is ectopically expressed in somatic cells (Fuhrmann et
al., 2001). Owing to the permissive role of Oct4 in midbrain
development shown in spg mutants, ectopic expression of
Oct4 in GCNF−/− embryos should not induce ectopic
expression of midbrain markers, but rather it should maintain
the expression of these markers. In contrast, the expression of
these markers is either reduced or lost in GCNF−/− embryos,
suggesting that the defects in midbrain development are not
due to ectopic Oct4 expression. Although murine Oct4
mRNA can restore gene expression in spg mutants, the role
of Oct4 in zebrafish may have different functions in midbrain
development from the mouse.
When Oct4 is ubiquitously expressed in transgenic mice
from the blastocyst stage, the expression of several brainmarkers is altered (Ramos-Mejia et al., 2005). Levels of Pax2
and En2 expression are transiently augmented at E8.5 but return
to normal at E9.5. At E8.5, Fgf8 signal was reduced in the
branchial arches and presomitic mesoderm. A broader and less-
confined domain of Fgf8 expression is found in the MHB and
ANR of one-third of the transgenic embryos. At E9.5, Fgf8
expression in the MHB is no longer affected. An increase of cell
death in the anterior neuroepithelium is observed at E9.5,
suggesting that this increased cell death may be responsible for
the reduction in brain size that was observed (Ramos-Mejia et
al., 2005). Thus, alteration ofOct4 expression may play a role in
disrupting normal mammalian brain development. Ectopic Oct4
expression in GCNF−/− embryos may contribute, to a certain
extent, to the midbrain defects but are clearly not the sole source
of the defects.
GCNF is expressed in the neuroepithelium during early
somitogenesis and in postmitotic neurons of the marginal zone
of the neuroepithelium in the developing brain at E15 (Bauer et
al., 1997; Fuhrmann et al., 2001; Susens et al., 1997), and
GCNF expression is up-regulated during RA-induced neural
differentiation of certain embryonic carcinoma cells and
embryonic stem cells (Bauer et al., 1997; Fuhrmann et al.,
2001; Gu et al., 2005). Thus, GCNF likely plays a role in
neurogenesis and/or neuronal differentiation. In this study, we
observed that no mature neurons are generated in the midbrain
of GCNF−/− embryos at E9.5, and significant cell death is
observed, suggesting the possibility that once generated
midbrain cells die. Recent studies in a mouse embryonic
carcinoma cell line demonstrate that GCNF expression is
critical for aggregation of neuronal cells, differentiation, and
maturation of neuronal precursor cells (Sattler et al., 2004). In
the future, it will be important to investigate how loss of GCNF
function affects neuronal differentiation and the expression of
important regulatory factors and marker genes. In conclusion,
there is a clear disruption of midbrain formation in GCNF−/−
embryos. It is likely that GCNF will probably play a more
widespread role in neuronal development of central nervous
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